ARIUS Research


Public list: Pharma Startups (4734) Cancer Therapeutics (1145)

ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics to treat cancer and other diseases. At the core of the Company is the company's unique, FunctionFIRST technology platform that generates and selects therapeutic antibodies based on their activity. This antibody generation engine has enabled ARIUS to grow a pipeline of more than 500 antibody drug candidates and five of ARIUS' six lead products target cancer stem cells. In addition to the antibodies ...Show all

ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics to treat cancer and other diseases. At the core of the Company is the company's unique, FunctionFIRST technology platform that generates and selects th...Show all

Company (Acquired)

Phone:

Fax:




Ontario, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ARIUS Research $0M Jul 23, 2008
Threshold Pharmaceuticals $106.4M Aug 2, 2017
CAN Center for Automation in Nanobiotech $0M Feb 6, 2019
See all 26 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ARIUS Research Jobs

jobs by Indeed job
						search

Board Members

Competitors

Company Status Description Investors
See all 26 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Antibody therapy of tumors Mar 07, 2006 Feb 10, 2009 Patent
Cancerous disease modifying antibodies Feb 22, 2007 Feb 03, 2009 Patent